CN1238024C - Chinese traditional medicine for treating insufficiency of kidney-yang and preparaton method - Google Patents
Chinese traditional medicine for treating insufficiency of kidney-yang and preparaton method Download PDFInfo
- Publication number
- CN1238024C CN1238024C CNB200410021412XA CN200410021412A CN1238024C CN 1238024 C CN1238024 C CN 1238024C CN B200410021412X A CNB200410021412X A CN B200410021412XA CN 200410021412 A CN200410021412 A CN 200410021412A CN 1238024 C CN1238024 C CN 1238024C
- Authority
- CN
- China
- Prior art keywords
- kidney
- treatment
- insufficiency
- fructus
- yang
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese traditional medicine for treating insufficiency of kidney-yang and a preparing method thereof. The Chinese traditional medicine is composed of the following raw materials of the following proportion by weight: 220 to 280 of red ginseng, 390 to 445 of male silkworm moths, 390 to 445 of epimedium (preparation), 390 to 445 of wolfberry fruit, 390 to 445 of mulberry, 220 to 280 of Herba Cistanches (preparation), 130 to 190 of walnut kernels, 100 to 170 of Chinese magnoliavine fruit, 120 to 190 of geckos, 35 to 70 of hippocampus, 35 to 70 of Chinese caterpillar fungus, 220 to 280 of prepared fleeceflower roots and 220 to 280 of milkvetch seeds. The present invention mainly treats old people's body weakness, body weakness after illness, insufficiency of kidneys, impotence, gonacratia, premature ejaculation, soreness and weakness of waists and knees, intolerance of cold limbs, ennui, weakness, dizziness, enechema, continuous dribble of urine, amnesia, severe coma, etc. The present invention has the advantages of short courses of treatment, no side effects, treatment for both manifestation and root causes of diseases, obvious therapeutic effects, etc.; besides, the present invention takes effect quickly; therefore, the effect on prolonging lives is achieved. Simultaneously, the present invention which can also reduce oxygen consumption and increase the resistance of hearts to oxygen deficiency has an obvious effect on nourishing mind.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of nephropathy, relate in particular to the Chinese medicine and preparation method thereof that a kind of QI invigorating is added the treatment insufficiency of kidney-YANG of essence, kidney-reinforcing Yang-strengthening.
Background technology
Along with population middle-aged and elderly people ratio rises gradually, old and feeble with how slow down aging has become the world of medicine's question of common concern.The many duties of old and feeble and relevant disease with aging in kidney, suffering from a deficiency of the kidney is a kind of multiple difficult disease, is a difficult problem that perplexs medical circle, decline for seeing with kidney yang (void) especially in the nephropathy more, also be the basic reason that makes people's aging and suffer from a deficiency of the kidney.There is investigation to show that the old people of China about 70% is partial to insufficiency of kidney-YANG.People in middle age, physiological function begins to descend, and is the important stage of prevention and slow down aging.The kidney being the origin of congenital constitution, and kidney yang is easily empty, thus see impotence due to deficiency of the kidney, the seminal emission premature ejaculation, fatigue and weakness forgetful dusk such as being had a liking for.If can strengthen this moment the taking good care of of kidney, slow down aging and medical care for the aged health care are had the important clinical meaning.
At the Western medicine that is used for preventing and treating aging, major part is a hormone medicine at present, and side effect is bigger, can separate needing of a period of time, but life-time service has dependency, cures the symptoms, not the disease.The Chinese medicine the kidney invigorating can integrally-regulated human nerve, endocrine and immune system, delay with age and the T Lymphocyte Apoptosis quickened, and the gene expression of the old and feeble inherited characteristic of influence reflection.
Existing prevention and the old and feeble Chinese patent medicine of treatment though as JINGUI SHENQI WAN, kidney tonifying sheet, YANSHENG HUBAO YE etc. certain curative effect is arranged, act on not obviously, can not carry out Comprehensive Treatment to suffering from a deficiency of the kidney, and the course of treatment are long, the actual therapeutic poor effect.
Contain this Chinese crude drug composition of male Bombycis mori in the Chinese medicine that some treatment is suffered from a deficiency of the kidney, because male Bombycis mori oiliness, gas raw meat, salty in the mouth, the preparation mouthfeel that causes containing this medicine is relatively poor.
Summary of the invention
Technical problem to be solved by this invention is Chinese medicine of the treatment insufficiency of kidney-YANG that provides at the problems referred to above and preparation method thereof, the present invention has short treating period, instant effect, nontoxic, side effect, characteristics such as therapeutic effect is remarkable, the present invention is used as medicine after earlier male Bombycis mori being processed, and has alleviated the bad smell that male Bombycis mori directly is used as medicine.
The weight ratio scope of each raw material of the present invention be through the inventor carry out a large amount of grope to sum up with experimentation draw, the weight ratio of each raw material all has curative effect preferably in following weight range, the present invention adopts following 13 kinds of medicines to make up, make each efficacy of drugs produce synergism these drug regimens, thereby effectively prevention and slow down aging, treatment are suffered from a deficiency of the kidney.
In order to address the above problem, the present invention is achieved in that it is to be made of by weight following raw material:
Radix Ginseng Rubra: male Bombycis mori: Herba Epimedii (system): Fructus Lycii: Fructus Mori: Herba Cistanches (system): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=(220-280): (390-445): (390-445): (390-445): (390-445): (220-280): (130-190): (100-170): (120-190): (35-70): (35-70): (220-280): (220-280).
The present invention can adopt the conventional method of Chinese medicine preparation to make any conventional oral formulations, as dosage forms such as tablet, capsule, powder, granule, oral liquid, syrup, Emulsion, suspensoids.
Its preparation method may further comprise the steps:
(1). get the airtight steeping in wine of male Bombycis mori by above-mentioned weight ratio, filter, decompression filtrate recycling ethanol gets the male silkworm moths spirit immersion;
(2). add cyclodextrin in above-mentioned male silkworm moths spirit immersion, the male silkworm moths spirit immersion is with the cyclodextrin mixing and make into the enclose state, gets male silkworm moths spirit immersion clathrate, and drying is pulverized, and gets fine powder A;
(3). get Radix Ginseng Rubra, Cordyceps, Fructus Lycii, Semen Juglandis, Fructus Schisandrae Chinensis, Radix Polygoni Multiflori Preparata, Gecko, Herba Cistanches (system), Hippocampus by above-mentioned weight ratio, alcohol extraction, merge extractive liquid, filters, and gets liquor C;
(4). get Fructus Mori, Herba Epimedii (system), Semen Astragali Complanati by above-mentioned weight ratio and decoct with water, filter, filtrate D, be concentrated into clear paste, cooling adds ethanol, stir, leave standstill, filter, get filtrate F, filtrate F and C are merged, reclaim ethanol and be concentrated into thick paste, be dried to dried cream, dried cream powder is broken, get fine powder B;
(5). two kinds of fine powders mixing of above-mentioned A, B had both been got active constituents of medicine of the present invention.
Last medicinal residues mix in the time of will getting liquor C and filtrate D in above-mentioned (3) step and (4) step, decoct with water, and get filtrate E, and filtrate D and E are merged, and carry out downwards by described in (4).
Active constituents of medicine in the above-mentioned step (5) adds the granule right amount of auxiliary materials, and mixing is granulated, and drying promptly gets granule.
Add solid preparation common dosage forms adjuvant in the active constituents of medicine in the above-mentioned step (5) and mix, technology is made tablet routinely, also can not add adjuvant and directly active constituents of medicine be made tablet.
After fine powder A, B in the above-mentioned step (5) mix, add lubricant or do not add, incapsulate, capsule.
Add 60%-85%% alcohol reflux secondary in above-mentioned (3) step, add 10 times of amounts for the first time, extracted 2 hours, add 8 times of amounts for the second time, extracted 2 hours, merge extracted twice liquid.
The weight ratio of each raw material of the present invention is:
Radix Ginseng Rubra: male Bombycis mori: Herba Epimedii (system): Fructus Lycii: Fructus Mori: Herba Cistanches (system): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=240: 407: 417: 417: 427: 260: 163: 139: 170: 45: 45: 235: 235.
Above-mentioned Radix Ginseng Rubra can use Radix Panacis Quinquefolii, Radix Codonopsis, Radix Pseudostellariae to replace; The available Radix Morindae Officinalis of Herba Epimedii (system), Rhizoma Curculiginis replace; The available Cornu Cervi Pantotrichum of Herba Cistanches (system) replaces; Semen Astragali Complanati can replace with Semen Cuscutae; Fructus Lycii can replace with Fructus Ligustri Lucidi.
Advantage of the present invention and effect are as follows: the present invention is a kidney invigorating class pure Chinese medicinal preparation, can integrally-regulated human nerve, endocrine and immune system, delay with age and the T Lymphocyte Apoptosis quickened, and the gene expression of the old and feeble inherited characteristic of influence reflection.Cure mainly old asthenia, body void after being ill, impotence due to deficiency of the kidney, the seminal emission premature ejaculation, soreness of the waist and knees, aversion to cold and cold limbs, fatigue and weakness, vertigo and tinnitus, dribble of urine are not to the greatest extent, have a liking for forgetful dusk etc., have short treating period, instant effect is nontoxic, side effect, treating both the principal and secondary aspects of a disease, advantages such as therapeutic effect is remarkable, thus reached the effect of life lengthening, and the present invention simultaneously can also reduce oxygen consumption, increase heart to anoxybiotic tolerance, have remarkable brain strengthening function, also can improve the resistance against diseases of body, the present invention has adopted the technology of being used as medicine behind " male Bombycis mori " first enclose, the bad smell of having avoided male Bombycis mori directly to be used as medicine can be accepted this agent by the patient on mouthfeel.
The specific embodiment
Below routine by experiment beneficial effect of further setting forth medicine of the present invention, these experiments comprise pharmacodynamic experiment, long term toxicity test and clinical trial.
(experimental example one)
Long-term toxicity test for animals
Granule rat long term toxicity test of the present invention is divided into four groups, large, medium and small dosage and matched group, and 20 every group, male and female half and half, successive administration 2 months is put to death then.10 of heavy dose of groups, in, low dose and matched group all put to death, and does the pathology inspection.Heavy dose of 10 in addition of organizing stop administration and normally raise the same processing of two weeks, also do the pathology inspection, observe its result.
One, censorship material: the rat heart, liver, spleen, lung, kidney, brain, adrenal gland and testis (ovary) tissue.
Two, censorship purpose: observe the toxic action of granule of the present invention, observe variations such as its tissue to the rat heart, liver, spleen, lung, kidney, brain, adrenal gland and testis (ovary).
Totally 80 examples are organized in censorship, and dislocation is put to death rat and removed internal organs, conventional fixing (10% formalin) paraffin section, HE dyeing, light microscopy checking.
Three, finding is described below by various dose under the mirror:
1, heavy dose of group: totally 20, wherein preceding 10 visible livers have in the 2 routine sinus hepaticus and are full of erythrocyte, are the congestion shape, and hepatocyte does not see significant change; Visible inflammatory cell infiltration in the matter is the lobule class and changes between lungs 2 examples, and visible most erythrocyte in the 1 routine alveolar space are arranged, and is hemorrhage shape; Kidney has and is full of erythrocyte between 1 example in the matter, is congested shape and changes.Back 10 examples wherein liver have 3 examples to be the congestion shape; The visible hemorrhage and interstitial inflammation of lungs sexually revises, other organize heart-myocardial cell and between matter, spleen-blood marrow and red pulp, brain-grey matter and blood vessel, each cell of testis-spermatogenic epithelium and between matter and adrenal gland there is no obvious change.
2, middle dosage group: totally 20 examples, wherein liver has in the 4 routine sinus hepaticus and is the congestion shape, lungs also as seen, hemorrhage and interstitial inflammation sexually revises, other tissue shows no obvious abnormalities change.
3, small dose group: totally 20 examples, its cardiac have between 1 example the matter blood vessel be full of erythrocyte to be hemorrhage shape, and congestion that the change of liver and liver is all identical with big or middle dosage group and inflammatory change.
Small dose group has spermatogenic cell disappearance in the visible convoluted seminiferous tubule of 1 routine testis tissue, only visible a little sustenticular cell, and other tissue there is no obvious change.
Four, brief summary
The congestion of all visible liver of each dosage group of granule of the present invention, the hemorrhage and inflammatory of lungs changes, no dose-response relationship, the real animal id reaction that belongs to, and it is improper and cause with this empirical factor and have nothing to do to put to death animal.
2,1 routine heart and the congested no pathology meaning of 1 routine kidney
3, wherein small dose group only has 1 routine testis generation degeneration, and routine number is less, wouldn't illustrate relevant with this empirical factor, may be relevant age with Mus, be a kind of senile change.
4, granule of the present invention does not see that to each internal organs of rat (heart, liver, spleen, lung, kidney, brain, adrenal gland and testis) toxicity changes.
(experimental example two)
Clinical research
Granule of the present invention is the pure Chinese medicinal preparation of Shengang Dongling Medicine Inst development.Be the clinical efficacy of definite granule of the present invention and the safety of its use of observation, defend (94) No. 113 documentation requirements of medicine letter word according to the Liao Dynasty of Department of Public Health of Shanxi Province, unite by Liaoning Prov. Traditional Chinese Medicine Inst, General Hospital of Shenyang Railway Bureau and Liaoning People's Hospital and carry out 100 routine clinical observation on the therapeutic effect.Now the observed result comprehensive report is as follows.
The case source is the male for selecting to meet the door rash and the inpatient of syndrome of deficiency of kidney-YANG diagnosis at random, observation group's (granule of the present invention) 100 examples, 47.23 ± 8.05 years old mean age, minimum 29 years old, maximum 64 years old; Average course of disease 2.08 ± 1.24 years, the shortest 0.33, the longest 6 years; Severity extent before the treatment is investigated with average symptom integral, is 26.53 ± 6.47 minutes.Matched group 60 examples, 48.5 ± 9.19 years old mean age, minimum 30 years old, maximum 63 years old; Average course of disease 2.04 ± 1.18 years, the shortest 0.25, the longest 4.67 years; Average symptom integral 24.57 ± 6.69 minutes (seeing table 1 for details) before the treatment.Observation group and matched group patient are at age, the course of disease and the state of an illness (symptom integral value before the treatment) aspects, and difference that there are no significant by analysis (P＞0.05) points out two groups to have harmony and comparability.
The harmonious table of measuring of table 1 observation group and matched group
| Group | The example number | Mean age | The P value | Average course of disease | The P value | The state of an illness (average symptom integral) | The P value |
| Out-patient clinic and hospitalization |
| Observation group's matched group | 70 60 | 30 | 47.23±8.05 48.5±9.19 | ＞0.05 | 2.08±1.24 2.04±1.18 | ＞0.05 | 26.53±6.47 24.57±6.69 | ＞0.05 |
One, experimental technique
By table of random number, tell observation group's 100 example and matched group 60 examples at random.
Medication administration method: one bag of granule of the present invention (being provided by the Shengang Dongling Medicine Inst) a time, three times on the one oral, observes a course of treatment (4 week).Matched group 60 examples, contrast medicine be YANSHENG HUBAO YE (Shenyang flying dragon Medicines and Health Product group produces, lot number: 940316), a 20ml, once-a-day, sleep preceding 2 hours oral, observed for 4 weeks.All cases that is included into two groups are filled in unified case history observation table by full-time doctor, and other relevant kidney invigorating and YANG supporting medicine (containing Chinese medicine, Western medicine) all should be withdrawn with matched group by observation group.
Two, significance test
According to the requirement of this programme design, enumeration data is intended X with observation index
2Carry out significance test, measurement data is intended carrying out the T significance test.
Three, clinical observation result
(1) observation group and matched group curative effect are relatively
As shown in Table 2, observation group's produce effects 51 examples, effective 43 examples.Obvious effective rate is 51%, total effective rate 94%.Matched group produce effects 30 examples, effective 26 examples, obvious effective rate is 50%, total effective rate is 93.3%.Through X
2Check, two groups of treatment back obvious effective rates and total effective rate there are no significant difference, P＞0.05. to observation group and treatment of control group after comparison shows that of symptom integral value, after the treatment, observation group dropped to 10.02 ± 5.75 fens by 20.33 ± 4.29 minutes, and matched group dropped to 8.58 ± 4.74 fens by 18.93 ± 2.68 minutes, through check, two groups of treatment back symptom integral value differences are different not remarkable, P＞0.05 (seeing Table 3)
Table 2 observation group and matched group curative effect are relatively
| Group | The example number | Produce effects | Effectively | Invalid | Obvious effective rate % | Total effective rate % | The P value | |||
| Example | (％) | Example | (％) | Example | (％) | |||||
| Observation group's matched group | 100 60 | 51 30 | (51) (50) | 43 26 | (43) (43.3) | 6 4 | (6) (6.7) | 51 50 | 94 93.3 | ＞0.05 |
The symptom integral value relatively after table 3 observation group and the treatment of control group
| Group | The example number | Treatment back symptom integral value (X ± SD) | The P value |
| Observation group's matched group | 100 60 | 10.02±5.75 8.58±4.74 | ＞0.05 |
(2) clinical each the symptom curative effect of observation group and matched group relatively
The disease that syndrome of deficiency of kidney-YANG is seen in of observation group and treatment of control group is carried out curative effect relatively, only lethargy symptom matched group is better than observation group (P＜0.05), the curative effect of all the other primary and secondary symptoms, difference that there are no significant between two groups (P＞0.05). the symptom integral value is relatively before and after observation group's treatment, all symptoms all have significantly and significant difference (P＜0.05 or P＜0.001) extremely, particularly primary symptom shape such as soreness of the waist and knees, aversion to cold and cold limbs and indolent and listless weak, nocturia, dizzy, tinnitus grade symptom are improved significantly and therapeutical effect.
The clinical all symptom curative effects of table 4 observation group and matched group relatively
| Symptom | Observation group | Matched group | ||||
| The example number | Control preceding average integral | Control the back average integral | The example number | Control preceding average integral | Control the back average integral | |
| The floating empty impotence and seminal emission premature ejaculation dizzy tinnitus of the indolent and listless weak night pollakiuria dribble of urine forgetful One's spirits are drooping tongue white deep thready pulse of light fat tongue of soreness and weakness of waist and knees aversion to cold and cold limbs appearance or late a little less than | 100 97 53 74 96 68 42 52 70 75 33 82 84 98 | 4.84±1.24 4.12±1.24 3.30±1.61 3.61±1.89 2.17±0.64 1.88±0.66 1.76±0.69 1.62±0.75 1.81±0.77 1.76±0.75 2±0.61 1.87±0.49 1.49±0.55 1.64±0.54 | 1.61±1.14 1.19±1.19 0.85±1.22 2.11±1.36 0.59±0.66 0.63±0.67 0.57±0.59 0.54±0.64 0.64±0.61 0.8±0.70 0.73±0.76 1.13±0.72 0.73±0.80 0.95±0.66 | 60 56 12 32 58 33 29 17 37 37 23 32 49 57 | 5.47±0.89 4.29±1.17 2±0 3.31±1.20 2.52±0.60 2.18±0.68 1.93±0.80 1.71±0.69 1.76±0.64 1.78±0.67 2.04±0.64 2.66±0.60 1.92±0.89 1.95±0.93 | 1.78±1.24 1.29±1.22 0.83±0.94 1.78±1.13 0.45±0.68 0.61±0.83 0.59±0.68 0.29±0.47 0.46±0.56 0.65±0.54 0.30±0.56 1.44±1.01 0.78±0.90 1.19±1.09 |
Treatment back observation group and matched group be P＜0.05 relatively
(3) observation group's course of disease and therapeutic effect relationship are relatively
As shown in Table 5, in observation group's 100 examples, 3～6 months 2 people of the course of disease, 6～12 months 13 people, 1～3 year 61 people, 24 people more than 3 years.Total effective rate is respectively 100%, 100%, and 95.1% and 87.5%.Analyze through Ridit, all do not have produce effects difference between each course of disease patient's the curative effect, P＞0.05.
The table 5 observation group course of disease and therapeutic effect relationship are relatively
Group example digital display is imitated enabledisable total effective rate % P value
Example % example % example %
February above 21 (50) 1 (50) 100
Half a year above 13 7 (53.8) 6 (46.2) 100
＞0.05
More than 1 year 61 33 (54.1) 25 (41.0) 3 (4.9) 95.1
More than 3 years 24 10 (41.7) 11 (45.8) 3 (12.5) 87.5
(4) variation of serum testosterone content before and after observation group's treatment
The 30 routine patients of observation group have been carried out the twice serum testosterone Determination on content in treatment front and back, the result shows, treatment through a course of treatment, the serum testosterone is by the 405.08 ± 306.2ng/dl that treats after 258.02 preceding ± 232.76ng/dl rises to treatment, serum testosterone content has extremely significant difference, P＜0.001 before and after the treatment.This promptly points out, and granule of the present invention has the effect of rising serum testosterone content.
Serum testosterone changes of contents relatively before and after the treatment of table 8 observation group
Treatment back P value before the treatment of example number
30 258.02±232.76ng/dl 405.08±306.02ng/dl ＜0.001
Four, conclusion
Clinical observation result proves, granule of the present invention is not most, dizzy to the floating void of insufficiency of kidney-YANG finding soreness of the waist and knees, aversion to cold and cold limbs, appearance, sexual impotence, seminal emission, premature ejaculation and indolent and listless weak, nocturia, dribble of urine, tinnitus, lethargy etc. have better prevention and therapeutical effect, determined curative effect, and certain adjusting male hormone metabolism level arranged, having no side effect, is a kind of pure Chinese medicinal preparation of taking convenience.
(experimental example three)
Cure mainly relevant Pharmacodynamic test of active extract with function
One, experiment material
Granule of the present invention is provided by the Shengang Dongling Medicine Inst, and experiment is to carry out with the medicine that does not add excipient.
Dragon moth liquid longevity Dandong City east star pharmaceutical factory product batch number: 930301
Scopolamine Switzerland makes lot number: 136330
Rat, the supply of mice Liaoning Province institute of materia medica animal housing
Two, experiment and result
Granule of the present invention is to the influence of scopolamine induced mice memory acquisition disturbance, and body weight 18～22 restrains 95 of Kunming mouses, and male and female half and half are divided into five groups at random, 19 every group.Two groups of mouse gavaging co-content normal saline.Three groups gavage imperial moth liquid longevity 8.0ml/kg respectively in addition, granule 37.0 of the present invention and 18.5g/kg (crude drug), once a day, serve on 10 days, after the last administration 50 minutes, except that one group of normal saline group (blank), another group normal saline group (model group) and three administration group mices.
Three, brief summary
Originally experiment showed, that (1) granule of the present invention can significantly increase the sexual behaviour of castration mouse; (2) significantly increase the growth of castration mouse gonad organ, present the effect of androgen sample; (3) can obviously increase the sexual behaviour of rat, make to catch and obviously shorten when hiding, significantly increase and catch number of times, increase copulation and ejaculation frequency, prove that granule of the present invention has significant life essence-filling, marrow-benefitting, the effect of kidney invigorating and YANG supporting, its effect obviously are better than contrast medicine dragon moth liquid longevity.
The experiment proved that, granule of the present invention is to the mice of memory acquisition disturbance due to the scopolamine, in the time of significantly shortening the hiding of diving tower experiment of mice, obviously reduce errors number and significantly shorten the time of being shocked by electricity, show the effect that remarkable hypermnesis is arranged, and obviously be better than contrast medicine dragon moth liquid longevity.Experiment is proof also, and granule of the present invention can significantly tolerate the acute brain anoxia.The mice oxygen metabolism experiment showed, that this medicine can reduce oxygen consumption, increases heart to anoxybiotic tolerance, above-mentioned experiment as can be seen, granule of the present invention has remarkable brain strengthening function.
Experiment is proof also, and castration mouse is seriously lacked of proper care because of androgen, will influence organism endocrine metabolism and protein assimilation, makes body weight gain slow, but this medicine can obviously increase the growth of castration mouse body weight, obviously is better than normal saline and imperial moth liquid longevity.This medicine can obviously increase phagocytic index, increases liver, spleen, thymic weight, and showing has the effect that increases non-specific immunity, can improve the resistance against diseases of body.Experiment proves that also this medicine can increase mice pole-climbing endurance and swimming time reaches more than one times.These experiments illustrate that all this medical instrument has significant strong effect.
" embodiment one " raw material of the present invention constitutes and it is prepared into the technology of granule
A kind of Chinese medicine for the treatment of insufficiency of kidney-YANG of the present invention is to be made of by weight following raw material:
Radix Ginseng Rubra: male Bombycis mori: Herba Epimedii (system): Fructus Lycii: Fructus Mori: Herba Cistanches (system): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=240: 407: 417: 417: 427: 260: 163: 139: 170: 45: 45: 235: 235;
Its method that is prepared into granule is comprised the steps:
(1). get male Bombycis mori by above-mentioned weight ratio and add the 50 degree Chinese liquor airtight immersions of 6 times of amounts, filter, filtrate is in 0.1Mpa, 45 ℃ of decompression recycling ethanols, the male silkworm moths spirit immersion, to the male silkworm moths spirit immersion be every milliliter of solution that contains the 2g crude drug;
(2). in above-mentioned male silkworm moths spirit immersion, add beta-schardinger dextrin-, the consumption ratio of beta-schardinger dextrin-and male silkworm moths spirit immersion is 1: 1, with beta-schardinger dextrin-and male silkworm moths spirit immersion mixing, grinds, use mortar in a small amount, ground 2 hours down with room temperature such as ball mill or colloid mill, refiner, high-shearing dispersion emulsifying machines slightly in a large number, high-shearing dispersion emulsifying machine got final product in 15 minutes, get final product male silkworm moths spirit immersion clathrate, at 60 ℃ of vacuum dryings, pulverize, cross 80 mesh sieves, get fine powder A;
(3). get Radix Ginseng Rubra, Cordyceps, Fructus Lycii, Semen Juglandis, Fructus Schisandrae Chinensis, Radix Polygoni Multiflori Preparata, Gecko, Herba Cistanches (system), Hippocampus by above-mentioned weight ratio, add 65% alcohol reflux secondary, add for the first time 10 times of amounts, extracted 2 hours, for the second time add 8 times of amounts, extracted 2 hours, merge extracted twice liquid, filter, get liquor C;
(4). get after Fructus Mori, Herba Epimedii (system), Semen Astragali Complanati add 15 times of amounts of water and soak 8 hours by above-mentioned weight ratio, decocted 2 hours, filter, must filtrate D, being concentrated into relative density is the clear paste of 1.0 (70 ℃), is chilled to room temperature, adds ethanol, make to contain alcohol amount and reach 70%, fully stir, leave standstill, filter, get filtrate F, filtrate F and C are merged, reclaim ethanol and be concentrated into thick paste, become dried cream in 80 ℃ of following vacuum dryings, dried cream powder is broken, cross 130 mesh sieves, get fine powder B, standby;
(5). two kinds of fine powders of above-mentioned A, B are mixed, get active constituents of medicine of the present invention;
(6). add steviosin in active component of the present invention, cane sugar powder is an amount of, mixing is granulated with 6% hydroxypropyl emthylcellulose alcoholic solution, and 60 ℃ of dryings promptly get granule.
" embodiment two " raw material of the present invention constitutes and it is prepared into the technology of granule
A kind of Chinese medicine for the treatment of insufficiency of kidney-YANG of the present invention is to be made of by weight following raw material: Radix Pseudostellariae: male Bombycis mori: Herba Epimedii (system): Fructus Lycii: Fructus Mori: Herba Cistanches (system): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=220: 390: 390: 390: 390: 220: 130: 100: 120: 35: 35: 220: 220;
Its method that is prepared into granule is comprised the steps:
(1). get male Bombycis mori by above-mentioned weight ratio and add the airtight immersion of 10 times of amount Chinese liquor (80 degree), filter, filtrate is in 0.15Mpa, 50 ℃ of decompression recycling ethanols, the male silkworm moths spirit immersion, to the male silkworm moths spirit immersion be every milliliter of solution that contains the 0.5g crude drug;
(2). add gamma-cyclodextrin in above-mentioned male silkworm moths spirit immersion, the consumption ratio of male silkworm moths spirit immersion and gamma-cyclodextrin is 1: 2, with male silkworm moths spirit immersion and beta-schardinger dextrin-mixing, homogenate, get final product male silkworm moths spirit immersion clathrate, 65 ℃ of vacuum dryings are pulverized, cross 120 mesh sieves, get fine powder A;
(3). get Radix Ginseng Rubra, Cordyceps, Fructus Lycii, Semen Juglandis, Fructus Schisandrae Chinensis, Radix Polygoni Multiflori Preparata, Gecko, Herba Cistanches (system), Hippocampus by above-mentioned weight ratio, add 80% alcohol reflux secondary, add for the first time 12 times of amounts, extracted 2 hours, for the second time add 9 times of amounts, extracted 2 hours, merge extracted twice liquid, filter, it is standby to get liquor C and medicinal residues;
(4). get after Fructus Mori, Herba Epimedii (system), Semen Astragali Complanati add 10 times of amounts of water and soak 12 hours by above-mentioned weight ratio, decocted 3 hours, filter, must filtrate D and medicinal residues; With these medicinal residues and in (3) step the medicinal residues of gained mix, decoct with water 3 hours, filter, filtrate E, filtrate D and E are merged, and being concentrated into relative density is the clear paste of 0.9 (70 ℃), is chilled to room temperature, adds ethanol, make to contain alcohol amount and reach 55%, fully stir, leave standstill, filter, get filtrate F, filtrate F and C are merged, reclaim ethanol and be concentrated into thick paste, become dried cream in 80 ℃ of following vacuum dryings, dried cream powder is broken, cross 70 mesh sieves, get fine powder B, standby;
(5). two kinds of fine powders of above-mentioned A, B are mixed, get active constituents of medicine of the present invention;
(6). add steviosin in active component of the present invention, lactose is an amount of, mixing is done binding agent with 8% hydroxypropyl emthylcellulose alcoholic solution, granulate, 60 ℃ of dryings, packing promptly gets granule.Wherein lactose can be replaced by similar medicine such as glucose, dextrin, mannitol.
" embodiment three " raw material of the present invention constitutes and it is prepared into the technology of capsule
A kind of Chinese medicine for the treatment of insufficiency of kidney-YANG of the present invention is to be made of by weight following raw material: Radix Panacis Quinquefolii or Radix Codonopsis: male Bombycis mori: Herba Epimedii (system): Fructus Lycii: Fructus Mori: Cornu Cervi Pantotrichum: Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Cuscutae=280: 445: 445: 445: 445: 280: 190: 170: 190: 70: 70: 280: 280;
Its technology that is prepared into capsule is comprised the steps:
(1). get male Bombycis mori by above-mentioned weight ratio and add the Chinese liquor airtight immersion of 3 times of amounts, filter, filtrate is in 0.1Mpa, 35 ℃ of decompression recycling ethanols, to the male silkworm moths spirit immersion be every milliliter of male silkworm moths spirit immersion that contains the 4g crude drug;
(2). add alpha-cyclodextrin in above-mentioned male silkworm moths spirit immersion, the consumption ratio of male silkworm moths spirit immersion and alpha-cyclodextrin is 1: 0.5, with male silkworm moths spirit immersion and alpha-cyclodextrin mixing, homogenate gets male silkworm moths spirit immersion clathrate, at 55 ℃ of following vacuum dryings, pulverize, cross 70 mesh sieves, get fine powder A;
(3). get Radix Ginseng Rubra, Cordyceps, Fructus Lycii, Semen Juglandis, Fructus Schisandrae Chinensis, Radix Polygoni Multiflori Preparata, Gecko, Herba Cistanches (system), Hippocampus by above-mentioned weight ratio, add 75% alcohol reflux secondary, add for the first time 8 times of amounts, extracted 3 hours, for the second time add 9 times of amounts, extracted 2 hours, merge extracted twice liquid, filter, it is standby to get liquor C and medicinal residues;
(4). get after Fructus Mori, Herba Epimedii (system), Semen Astragali Complanati add 20 times of amounts of water and soak 6 hours by above-mentioned weight ratio, decocted 2 hours, filter, must filtrate D and medicinal residues; With these medicinal residues and in (3) step the medicinal residues of gained mix, decoct with water 1 hour, filter, filtrate E, filtrate D and E are merged, and being concentrated into relative density is the clear paste of 1.1 (70 ℃), is chilled to 8 ℃, adds ethanol, make to contain alcohol amount and reach 70%, fully stir, leave standstill, filter, get filtrate F, filtrate F and C are merged, reclaim ethanol and be concentrated into thick paste, become dried cream in 80 ℃ of following vacuum dryings, dried cream powder is broken, cross 90 mesh sieves, get fine powder B, standby;
(5). will directly incapsulate after two kinds of fine powders mixing of above-mentioned A, B, get capsule.
To also can add the agent of capsule traditional lubrication after two kinds of fine powders mixing of A, B in above-mentioned (5) step, in incapsulating then.
" embodiment four "
After two kinds of fine powders mixing of A, B in the embodiment one described step (5), mix with tablet adjuvant commonly used, tabletting had both got medicinal tablet of the present invention, and other is with embodiment one; The conventional adjuvant that wherein prepares tablet can be any one in the similar medicines such as lactose, glucose, starch, dextrin, mannitol.
" embodiment five "
The present invention is made of by weight following raw material:
Radix Ginseng Rubra: male Bombycis mori: Herba Epimedii (system): Fructus Lycii: Fructus Mori: Herba Cistanches (system): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=250: 417: 420g, 440: 427: 260: 180: 141: 170: 45: 55: 245: 235.
Preparation method is with embodiment one.
" embodiment six "
The present invention is made of by weight following raw material:
Radix Ginseng Rubra: male Bombycis mori: Radix Morindae Officinalis: Fructus Lycii: Fructus Mori: Cornu Cervi Pantotrichum: Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=220: 445: 395: 445: 420: 220: 140: 100: 140: 50: 70: 270: 230;
Preparation method is with embodiment one.
" embodiment seven "
The present invention is made of by weight following raw material:
Radix Ginseng Rubra: male Bombycis mori: Rhizoma Curculiginis: Fructus Lycii: Fructus Mori: Herba Cistanches (system): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=235: 410: 395: 400: 415: 235: 169: 120: 140: 50: 45: 265: 215;
Preparation method is with embodiment two.
" embodiment eight "
The present invention is made of by weight following raw material:
Radix Ginseng Rubra: male Bombycis mori: Herba Epimedii (system): Fructus Lycii: Fructus Mori: Herba Cistanches (system): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=260: 425: 415: 425: 420: 255: 175: 155: 160: 60: 55: 270: 260
Preparation method is with embodiment three.
Claims (10)
1. Chinese medicine for the treatment of insufficiency of kidney-YANG, it is characterized in that it is to be made of Radix Ginseng Rubra by weight following raw material: male Bombycis mori: Herba Epimedii (processed): Fructus Lycii: Fructus Mori: Herba Cistanches Deserticolae (processed): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=220-280: 390-445: 390-445: 390-445: 390-445: 220-280: 130-190: 100-170: 120-190: 35-70: 35-70: 220-280: 220-280.
2. a kind of Chinese medicine for the treatment of insufficiency of kidney-YANG according to claim 1, the weight proportion that it is characterized in that its each raw material is a Radix Ginseng Rubra: male Bombycis mori: Herba Epimedii (processed): Fructus Lycii: Fructus Mori: Herba Cistanches Deserticolae (processed): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=240: 407: 417: 417: 427: 260: 163: 139: 170: 45: 45: 235: 235.
3. a kind of Chinese medicine for the treatment of insufficiency of kidney-YANG according to claim 1 and 2 is characterized in that described Radix Ginseng Rubra can use Radix Panacis Quinquefolii, Radix Codonopsis, Radix Pseudostellariae to replace; Herba Epimedii (processed) can use Radix Morindae Officinalis, Rhizoma Curculiginis to replace.
4. a kind of Chinese medicine for the treatment of insufficiency of kidney-YANG according to claim 1 and 2 is characterized in that described Herba Cistanches Deserticolae (processed) can replace with Cornu Cervi Pantotrichum; Semen Astragali Complanati can replace with Semen Cuscutae; Fructus Lycii can replace with Fructus Ligustri Lucidi.
5. preparation method of Chinese medicine for the treatment of insufficiency of kidney-YANG, it is characterized in that it is to be made of Radix Ginseng Rubra by weight following raw material: male Bombycis mori: Herba Epimedii system: Fructus Lycii: Fructus Mori: Herba Cistanches Deserticolae (processed): Semen Juglandis: Fructus Schisandrae Chinensis: Gecko: Hippocampus: Cordyceps: Radix Polygoni Multiflori Preparata: Semen Astragali Complanati=220-280: 390-445: 390-445: 390-445: 390-445: 220-280: 130-190: 100-170: 120-190: 35-70: 35-70: 220-280: 220-280;
Its preparation method may further comprise the steps:
(1). get the airtight steeping in wine of male Bombycis mori by above-mentioned weight ratio, filter, decompression filtrate recycling ethanol gets the male silkworm moths spirit immersion;
(2). add cyclodextrin in above-mentioned male silkworm moths spirit immersion, the male silkworm moths spirit immersion is with the cyclodextrin mixing and make into the enclose state, gets male silkworm moths spirit immersion clathrate, and drying is pulverized, and gets fine powder A;
(3). get Radix Ginseng Rubra, Cordyceps, Fructus Lycii, Semen Juglandis, Fructus Schisandrae Chinensis, Radix Polygoni Multiflori Preparata, Gecko, Herba Cistanches Deserticolae (processed), Hippocampus by above-mentioned weight ratio, alcohol extraction, merge extractive liquid, filters, and gets liquor C;
(4). get Fructus Mori, Herba Epimedii (processed), Semen Astragali Complanati by above-mentioned weight ratio and decoct with water, filter, filtrate D, be concentrated into clear paste, cooling, add ethanol, stir, leave standstill, filter, get filtrate F, filtrate F and C are merged, reclaim ethanol and be concentrated into thick paste, be dried to dried cream, dried cream powder is broken, get fine powder B;
(5). two kinds of fine powders mixing of above-mentioned A, B had both been got active constituents of medicine of the present invention.
6. a kind of preparation method of Chinese medicine for the treatment of insufficiency of kidney-YANG according to claim 5 is characterized in that the active constituents of medicine in the described step (5) is added the granule right amount of auxiliary materials, and mixing is granulated, and drying promptly gets granule.
7. a kind of preparation method of Chinese medicine for the treatment of insufficiency of kidney-YANG according to claim 5, it is characterized in that mixing with adding tablet adjuvant commonly used in the active constituents of medicine in the described step (5), tabletting is made tablet, also can not add adjuvant and directly active constituents of medicine be made tablet.
8. a kind of preparation method of Chinese medicine for the treatment of insufficiency of kidney-YANG according to claim 5, it is characterized in that fine powder A, B in the described step (5) mixes after, add lubricant or do not add, in incapsulating, capsule.
9. a kind of preparation method of Chinese medicine for the treatment of insufficiency of kidney-YANG according to claim 5 is characterized in that adding 65% alcohol reflux secondary in described the 3rd step, adds 10 times of amounts for the first time, extracted 2 hours, for the second time add 8 times of amounts, extracted 2 hours, merge extracted twice liquid.
10. a kind of preparation method of Chinese medicine for the treatment of insufficiency of kidney-YANG according to claim 5, last medicinal residues mix when it is characterized in that will getting liquor C and filtrate D in described (3) step and (4) step, decoct with water, and get filtrate E, filtrate D and E are merged, carry out downwards by described in (4).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200410021412XA CN1238024C (en) | 2004-03-17 | 2004-03-17 | Chinese traditional medicine for treating insufficiency of kidney-yang and preparaton method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200410021412XA CN1238024C (en) | 2004-03-17 | 2004-03-17 | Chinese traditional medicine for treating insufficiency of kidney-yang and preparaton method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1562337A CN1562337A (en) | 2005-01-12 |
| CN1238024C true CN1238024C (en) | 2006-01-25 |
Family
ID=34479810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200410021412XA Expired - Fee Related CN1238024C (en) | 2004-03-17 | 2004-03-17 | Chinese traditional medicine for treating insufficiency of kidney-yang and preparaton method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1238024C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100342896C (en) * | 2005-07-15 | 2007-10-17 | 王家军 | Compounding liniment contg. traditional Chinese medicine and Western medicine for treating hoary hair |
| CN100341562C (en) * | 2005-08-17 | 2007-10-10 | 秦杰 | Health caring wine for strengthening kidney and enhancing energy |
| CN102139017B (en) * | 2011-04-11 | 2012-12-12 | 乔晓峰 | Raw materials of kidney tonifying spirits, kidney tonifying spirits and preparation method of kidney tonifying spirits |
| CN102872267A (en) * | 2012-10-12 | 2013-01-16 | 绿之韵生物工程集团有限公司 | Traditional Chinese medicine composition for resisting fatigue and tonifying kidney, and preparation method thereof |
| CN103316159B (en) * | 2013-05-20 | 2016-02-24 | 缪长法 | A kind of Chinese medicine for the treatment of deficiency of the kidney and preparation method thereof |
| CN103340405B (en) * | 2013-07-11 | 2017-07-28 | 陕西大志药业有限公司 | A kind of health food for relieving physical fatigue and preparation method thereof |
| CN104069265A (en) * | 2014-07-15 | 2014-10-01 | 董宝珍 | Traditional Chinese medicine wine for treating impotence and preparation method thereof |
| CN105343319A (en) * | 2015-11-20 | 2016-02-24 | 王立鑫 | Health preserving pill with kidney tonifying and qi benefiting efficacy |
| CN105998716A (en) * | 2016-07-26 | 2016-10-12 | 李厚建 | Traditional Chinese medicine composition for treating impotence |
-
2004
- 2004-03-17 CN CNB200410021412XA patent/CN1238024C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1562337A (en) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1457808A (en) | Iron scale dendrobium compound preposition and preparation and use | |
| CN101032560A (en) | Chinese medicine composition for treating somnipathy and preparing method thereof | |
| CN1528407A (en) | Composition for preventing and treating diabets mellitus | |
| CN1238024C (en) | Chinese traditional medicine for treating insufficiency of kidney-yang and preparaton method | |
| CN1233387C (en) | Chinese compound medicine for treating anhypnosis and its preparation metod | |
| CN1263494C (en) | Granule for treating puerperal galactozemia and its preparation method | |
| CN1528173A (en) | Royal jelly composition with improved sleep function | |
| CN1927331A (en) | Chinese medicine preparation for curing chronic heart failure | |
| CN1478508A (en) | Chinese medicinal composition for treating fatty liver and its preparation method | |
| CN101036722A (en) | Health-caring food for easing and improving climacteric Syndrome of men and the preparation thereof | |
| CN1055227C (en) | Medicine for treating masculine sterility | |
| CN1733089A (en) | Medicine for treating diabetes and its complications and process for preparing the same | |
| CN1682780A (en) | Medicine for treating uaemia and insufficiency of kidney-yang and kidney exhaustion and its preparing method | |
| CN1872273A (en) | Medication composition for treating cardiovascular diseases and cerebrovascular disease, and preparation method | |
| CN1857605A (en) | Medicine for treating chronic alcoholic hepatopathy and its preparing method | |
| CN1634463A (en) | Medicine for treating diabetes and production method thereof | |
| CN100350940C (en) | Medicine for treating diabetes and its complications and its preparing process | |
| CN1234407C (en) | Medicine for treating chronic prostatitis and its preparing method | |
| CN1042395C (en) | Queen ant extrat oral liquid and its preparation method | |
| CN101066294A (en) | Chinese medicine prepn for invigorating kidney to reduce urination and its prepn | |
| CN1240414C (en) | Prepared Chinese medicine for improving function of female ovary as well as preparation method and application in pharmacy | |
| CN1666658A (en) | Health products adapted for diabetic and production method thereof | |
| CN1689637A (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN1137698C (en) | Preparation containing peanut leaf extract and its preparing process | |
| CN1973850A (en) | Medicine composition for treating allergic rhinitis and its prepn process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060125 Termination date: 20160317 |